Search Results 281-290 of 14906 for alt

1. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

   ... (ALT) or aspartate aminotransferase (AST) >3 × the upper limit of normal (ULN), f) Alkaline phosphatase >3 × ULN, g) Serum creatinine >2 × ULN; Antibiotic use ...

2. Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

   - Alanine Aminotransferase (ALT) < 5 x ULN; - Serum albumin ≥ 3.5 g/dL; - Serum Alkaline Phosphatase (ALP) ≤ 2 x ULN. - BMI ≥ 23 kg/m^2 at screening. Key ...

3. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease - Mayo Clinic

   AST and ALT must be < 2.5 x ULN for the lab. Adequate renal function within 28 days before study entry defined as serum creatinine ≤ 1.5 x ULN for the lab ...

4. Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery - Mayo Clinic

   SGPT (ALT) ≤ 3 x ULN; Creatinine ≤1.5 x ULN. Negative pregnancy test done ≤ 7 days prior to registration, for women of childbearing potential only. Patient ...

5. Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer - Mayo Clinic

   NOTE: If total bilirubin is out of range then direct bilirubin must be ≤ULN. Alanine transaminase (ALT) 2.5 x ULN (5 x ULN for patients with liver involvement); ...

6. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

   ... (ALT) \>2.5 × ULN (unless due to hepatic iron deposition) * Serum bilirubin \>ULN, if the elevation is associated with clinically symptomatic ...

7. Nedosiran in Pediatric Patients from Birth to 5 Years of Age with PH and Relatively Intact Renal Function - Mayo Clinic

   Liver function test (LFT) abnormalities: ALT and/or AST > 1.5 × ULN for age and gender 10. Known hypersensitivity to nedosiran, or any of its ingredients 11 ...

8. Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) - Mayo Clinic

   ... (ALT or AST) 3x higher than normal values at screening visit. Liver enzymes (ALT or AST) 3x higher than normal values at screening visit. Subject will be ...

9. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

   Serum ALT/AST ≤ 2.5 x ULN; Total bilirubin ≤ 1.5 x ULN; Cardiac ejection fraction ≥ 50% and no clinically significant ECG findings; Baseline oxygen ...

10. Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) - Mayo Clinic

    Liver abnormality/disease - Alanine transaminase (ALT) >2.5x upper limit of normal (ULN) or ALT>5xULN if documented HES with liver manifestations, or ...